Supernus Pharmaceuticals SUPN
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 47.79 | 1,050 | -4.27 | -45 | -3.22 | 1,420 |
| 2025Q2 | 31.52 | 1,064 | 2.15 | 22 | 1.65 | 1,382 |
| 2025Q1 | 32.75 | 1,031 | -1.14 | -12 | -0.87 | 1,347 |
| 2024Q4 | 36.16 | 1,036 | 1.50 | 15 | 1.13 | 1,368 |
| 2024Q3 | 31.18 | 1,007 | 3.92 | 38 | 2.90 | 1,343 |
| 2024Q2 | 26.75 | 957 | 2.11 | 20 | 1.52 | 1,316 |
| 2024Q1 | 34.11 | 929 | 0.01 | 0 | 0.01 | 1,304 |
| 2023Q4 | 28.94 | 922 | 0.13 | 1 | 0.09 | 1,278 |
| 2023Q3 | 27.57 | 912 | -1.74 | -16 | -1.24 | 1,285 |
| 2023Q2 | 30.06 | 920 | -0.09 | -1 | -0.05 | 1,293 |
| 2023Q1 | 36.23 | 912 | 1.88 | 17 | 0.97 | 1,792 |
| 2022Q4 | 35.67 | 886 | 2.93 | 25 | 1.50 | 1,703 |
| 2022Q3 | 33.85 | 853 | 0.21 | 2 | 0.10 | 1,693 |
| 2022Q2 | 28.92 | 841 | 0.94 | 8 | 0.47 | 1,695 |
| 2022Q1 | 32.32 | 828 | 3.12 | 26 | 1.54 | 1,640 |
| 2021Q4 | 29.16 | 816 | 0.30 | 2 | 0.15 | 1,689 |
| 2021Q3 | 26.67 | 810 | 2.70 | 22 | 1.38 | 1,555 |
| 2021Q2 | 30.79 | 786 | 3.08 | 24 | 1.54 | 1,573 |
| 2021Q1 | 26.18 | 754 | 0.76 | 6 | 0.38 | 1,507 |
| 2020Q4 | 25.16 | 745 | 4.23 | 31 | 2.04 | 1,504 |